
News|Articles|May 12, 2026
Supplements And Featured Publications
- Clinical Utility of GEMTESA® (vibegron) in Diverse Managed OAB Populations
Clinical Utility of GEMTESA® (vibegron) in Diverse Managed OAB Populations
This article is sponsored by Sumitomo Pharma America, Inc.
Latest CME
Trending on Managed Healthcare Executive
1
Prior authorization isn’t shrinking. Its savings are
2
Novo Nordisk launches Awiqli, a once-weekly basal insulin
3
David Chen, Pharm.D., on Kaiser Permanente's biosimilar strategy
4
Once-weekly pemvidutide begins phase 3 trial for MASH
5
















